ACL vs NEU

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

53MEDIUM

NEU

NEUREN FPO NZ [NEU]

47LOW

Score Breakdown

ACL NEU
Technical
62
61
Catalyst
88
50
Sentiment
50
50
Fundamental
67
62
Momentum
47
26
Risk Gate
36
43

Key Metrics

ACL Metric NEU
$423.4MMarket Cap$2.1B
520KAvg Volume (20d)725K
+7.3%Short Interest+4.9%
$2.97052-Week High$22.985
$1.83352-Week Low$11.000
+2.0%Daily Change+0.2%
$2.275Reference Price$16.530
+16.7%ROE+8.7%
+3.6%Profit Margin+47.1%

Active Signals

ACL Signals

Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading above both moving averages — the trend is your friend here
Above-average volume (1.7x) on a green day — buyers stepping up
Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)

NEU Signals

Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)
Piotroski F-Score strong (7/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
Earnings in sharp decline (-88% QoQ)

Ask Scout AI to compare ACL and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ACL vs ONE →ACL vs PHX →ACL vs PKY →ACL vs RHY →ACL vs TRI →
ACL Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).